
AliveCor, Inc. is a leading innovator in mobile cardiac care, leveraging deep learning to provide real-time, AI-powered ECG analysis. Their flagship product, the FDA-cleared KardiaMobile 6L, delivers instant, clinically validated detection of atrial fibrillation, bradycardia, tachycardia, and other arrhythmias directly from a smartphone. In addition to consumer devices, AliveCor offers an enterprise platform that enables clinicians and healthcare providers to monitor patients remotely, integrate seamlessly with electronic health records, and manage cardiac conditions with advanced analytics. The company distinguishes itself through rigorous data security—ISO 27001, SOC 2 Type 2, and HIPAA compliance—ensuring that patients and providers can trust its AI-driven solutions for safe, accurate cardiac monitoring.
AliveCor imagines a healthier world powered by access to personalized intelligent information, aiming to be the world's heart health partner. The company pioneers over-the-counter medical ECG devices, empowering consumers and patients to take care of their heart.
AliveCor, Inc. is a leading innovator in mobile cardiac care, leveraging deep learning to provide real-time, AI-powered ECG analysis. Their flagship product, the FDA-cleared KardiaMobile 6L, delivers instant, clinically validated detection of atrial fibrillation, bradycardia, tachycardia, and other arrhythmias directly from a smartphone. In addition to consumer devices, AliveCor offers an enterprise platform that enables clinicians and healthcare providers to monitor patients remotely, integrate seamlessly with electronic health records, and manage cardiac conditions with advanced analytics. The company distinguishes itself through rigorous data security—ISO 27001, SOC 2 Type 2, and HIPAA compliance—ensuring that patients and providers can trust its AI-driven solutions for safe, accurate cardiac monitoring.